Search by Drug Name or NDC

    NDC 24208-0446-02 Besivance 6 mg/mL Details

    Besivance 6 mg/mL

    Besivance is a OPHTHALMIC SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BESIFLOXACIN.

    Product Information

    NDC 24208-0446
    Product ID 24208-446_2b3a99b3-0edb-428b-ae41-67d297956a65
    Associated GPIs 86101007101820
    GCN Sequence Number 065230
    GCN Sequence Number Description besifloxacin HCl DROPS SUSP 0.6 % OPHTHALMIC
    HIC3 Q6W
    HIC3 Description OPHTHALMIC ANTIBIOTICS
    GCN 24317
    HICL Sequence Number 036350
    HICL Sequence Number Description BESIFLOXACIN HCL
    Brand/Generic Brand
    Proprietary Name Besivance
    Proprietary Name Suffix n/a
    Non-Proprietary Name Besifloxacin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route OPHTHALMIC
    Active Ingredient Strength 6
    Active Ingredient Units mg/mL
    Substance Name BESIFLOXACIN
    Labeler Name Bausch & Lomb Incorporated
    Pharmaceutical Class Quinolone Antimicrobial [EPC], Quinolones [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022308
    Listing Certified Through 2024-12-31

    Package

    NDC 24208-0446-02 (24208044602)

    NDC Package Code 24208-446-02
    Billing NDC 24208044602
    Package 1 BOTTLE, DROPPER in 1 CARTON (24208-446-02) / 2 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 2009-05-28
    NDC Exclude Flag N
    Pricing Information N/A